Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
DRGC82
|
|||
Drug Name |
VRC07-523LS
|
|||
Drug Type |
Antibody
|
|||
Indication | Human immunodeficiency virus-1 infection [ICD-11: 1C62; ICD-10: B20-B24] | Phase 1 | [1] | |
Company |
TaiMed Biologics
|
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT03735849) Evaluating the Safety and Pharmacokinetics of VRC-HIVMAB075-00-AB (VRC07-523LS) in the Sera and Mucosae of Healthy, HIV-Uninfected Adult Participants. U.S. National Institutes of Health. | |||
REF 2 | Clinical pipeline report, company report or official report of TaiMed Biologics. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.